N,N-Diethyl-1,4-cyclohexanediamine (cis- and trans- mixture)>95.0%(GC)5g

Dimethyl 2-bromo-1H-imidazole-4,5-dicarboxylate, 98.0%, 250mg

Hydrochloric acid, ROTI®Volum 0.1 mol/l - 0.1 N, ampoule, 1 piece, plastic packaging.

tert-Butyl 4-(pyrimidin-4-yl)piperazine-1-carboxylate, 95.0%, 1g

Fmoc-Phenylalaninol, 98%, 10g

3-Chloro-2-methoxyaniline, 95.0%, 10g

(R)-2-((5-Fluoro-2,4-dinitrophenyl)amino)propanamide, 95.0%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(1H-indol-3-yl)propanoic acid, 97%, 1g

2-(4,6-Dimethylpyrimidin-2-yl)ethanamine dihydrochloride, 95.0%, 5g

5-Bromo-2,4-dihydroxybenzoic acid hydrate, 98%, 1g

2-(4-Methoxy-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

3-(6-Chloro-1H-benzoimidazol-2-yl)-propionic acid, 95.0%, 250mg

Spiro[5.5]undecan-3-one, 95.0%, 250mg